Breaking News

$IVST Innovest Global Announces Patent is Approved for StemVax Therapeutics





Innovest Global Announces Patent is Approved for StemVax Therapeutics

CLEVELAND, July 25, 2018 (GLOBE NEWSWIRE) -- Innovest Global Inc. (OTC Pink Current:IVST) (the “Company” or “Innovest”), reports that the patent application for the technology being developed by StemVax Therapeutics was approved. The patent is granted under the category of “Cancer Antigens”, and related to the “treatment of cancer using vaccination therapy”.
“Patent approval is the trigger for us to engage major health organizations, to continue the progress toward the ‘StemVax Glioblast’ brain tumor vaccine going to market and improving peoples lives. After decades of research, it took nine years in the patent process, and is a transformational achievement,” said Dr. Dwain Morris-Irvin, President of Innovest’s Biotech Division. The patent application was filed in 2008 by a hospital research organization, and was co-authored by Dr. Morris-Irvin, who is also the StemVax Chief Science Officer. It is patent #US9764014B2.
“This is very significant. I am thrilled for the StemVax team, and in awe of how well positioned this technology is, how many people it can help, and how enthusiastic Dr. Morris-Irvin is about next steps,” said Dan Martin, CEO of Innovest Global. “Everyone who knows Dwain, knows his passion for this work. He and his colleagues sacrifice immensely and work very hard. The world is a better place thanks to professionals like these, and others, who are committed to the research process with no assurances of when, or even if, a breakthrough may occur. They deserve the utmost respect and admiration for their efforts.”
StemVax is organizing its market approach, and finalizing key arrangements. Sufficiently demonstrating valid intellectual property to Innovest was one of Innovest’s requirements to ultimately closing the StemVax transaction last week, which was pending since a Letter of Intent was signed and announced on March 19, 2018, contingent upon certain StemVax achievements. Innovest’s acquisition of a stake in StemVax was announced July 18, 2018, and marked the launch of the Innovest Biotechnology & Health Services Division. Look for much more to news to come soon about this exciting effort.


More about StemVax Therapeutics:
StemVax Therapeutics is a Translational Biotechnology Company that develops novel therapies for brain tumor patients. We focus our efforts on developing immunotherapeutic approaches to treating patients with Glioblastoma Multiforme (GBM), a devastating brain cancer. We also focus our research efforts on novel drug development to target Cancer Stem cells and other multi-resistant cancer cells. We seek to make a difference in patient’s lives. Bringing new beginnings to the market by developing novel therapeutics.
About Innovest Global, Inc.Innovest Global, Inc. (OTC Markets:IVST) is in the Conglomerates industry, a diversified holding company with operations in commercial and industrial products and services, energy, biotechnology, and health services. Innovest Global utilizes novel technology and marketing to efficiently acquire customers. Our primary growth strategy is to acquire existing companies in a select few industries, and attract new customers in cost effective ways. Currently, we have a Commercial & Industrial Division, and a Biotechnology & Health Services Division.
For more information, please visit: http://www.innovestglobal.com, and follow us on Twitter @innovestglobal.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical facts included in this press release are forward-looking statements. These statements relate to future events or to the Company's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond the Company's control which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to operations, results of operations, growth strategy and liquidity. Such risks, uncertainties and other factors, which could impact the Company and the forward-looking statements contained herein are included in the Company's filings with the OTC Markets. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

  • GlobeNewswireyesterday

    Innovest Global Announces Patent is Approved for StemVax Therapeutics

    Innovest Global Inc. (OTC Pink Current:IVST) (the “Company” or “Innovest”), reports that the patent application for the technology being developed by StemVax Therapeutics was approved. The patent is granted under the category of “Cancer Antigens”, and related to the “treatment of cancer using vaccination therapy”. After decades of research, it took nine years in the patent process, and is a transformational achievement,” said Dr. Dwain Morris-Irvin, President of Innovest’s Biotech Division.
  • GlobeNewswire3 days ago

    Innovest Global: Record Sales, Major Clients, Significant Growth Mark 1st Half 2018 Letter to Shareholders, Q2 Report

    CLEVELAND, July 23, 2018-- Innovest Global Inc., posted Q2 financial reports this morning, and the following Shareholder update from Dan Martin, Chairman and CEO:. Congratulations and thank you to our ...

  • GlobeNewswire8 days ago

    Innovest Global Acquires Stake in StemVax Therapeutics, Launching Biotechnology & Health Services Division

    Innovest Global Inc. (OTC Pink Current:IVST) (the “Company” or “Innovest”), a diversified holding company with operations in commercial and industrial products and services, launched its anticipated Biotechnology & Health Services Division today with the acquisition of a twenty percent interest in StemVax Therapeutics, a Translational Biotechnology Company that is currently developing a cancer vaccine therapy that enhances the patient’s immune response against brain tumors.

  • GlobeNewswire10 days ago

    Innovest Global Updates: Third Straight Month of Record Sales, New Corporate Website, and Focus on Expanding Investor Base -- Spotlight Growth

    A new update has been published on Innovest Global, Inc. (OTC PINK: IVST). Innovest Global, Inc. is a diversified holding company that focuses on acquiring niche, high-growth businesses that are capable of generating significant annual revenue. This represents a compound annual growth rate (CAGR) of 7.88% between 2016 and 2022.

  • GlobeNewswire16 days ago

    Innovest Global Third Straight Record Month of Sales and New Future Efforts Highlight July Shareholder Update

    Innovest Global Inc. (OTC Markets:IVST) (the “Company” or “Innovest”), a diversified holding company with operations in commercial and industrial products and services, energy, and health services, closed June with it’s third straight record monthly sales achievement, at $409K from it’s Commercial & Industrial Division. “We’re just getting started,” said Dan Martin, Innovest’s Chief Executive Officer.

  • GlobeNewswire29 days ago

    Innovest Global Discloses Byram Healthcare as Previously Awarded $650,000 Annual Call Center Contract

    Innovest Global Inc. (OTC Markets:IVST) (the “Company” or “Innovest”), a diversified holding company with operations in commercial and industrial products and services, and health services, today disclosed the name of Byram Healthcare as the previously announced award of a call center contract with a division of Fortune 500 global healthcare solutions company, Owens & Minor, Inc. Training of the initial twelve person team Innovest is deploying for Byram, was completed this week.

  • GlobeNewswirelast month

    Innovest Global New Corporate Website Sets Platform for Future, Highlights Value Proposition for Acquired Entities

    Innovest Global Inc. (OTC Markets:IVST) (the “Company” or “Innovest”) replaced its longstanding corporate website, which regularly achieved tens of thousands of views monthly, with a second generation evolution that best represents the company’s established trajectory, and introduces Innovest’s “Source of Strength” philosophy for acquired entities. “The most attractive acquisition targets focus on one thing – how Innovest can help them be more successful,” said Dan Martin, Innovest’s Chief Executive Officer. “’Source of Strength’ at its core represents our commitment to work as a team to strengthen the revenue, profitability, and operations of any company we acquire.

  • GlobeNewswirelast month

    Innovest Global Engages Hayden IR to Develop Comprehensive Investor Relations Program

    Innovest Global Inc. (OTC Markets:IVST) (the “Company” or “Innovest”), a diversified holding company with operations in commercial and industrial products and services, energy and health services, today announced that it has retained Hayden IR, a national investor relations consulting firm, to implement a strategic investor relations program grounded in best practices. Hayden IR will work to raise Innovest’s visibility within the investment community by strengthening its relationships and increasing awareness with the goal of ultimately enhancing shareholder value.

  • GlobeNewswire2 months ago

    Innovest Global, Inc. New Record $350K Sales in May, Premier Clients, New Institutional Investor Highlight our June Shareholder Update

    Innovest Global Inc. (OTC PINK:IVST) finished May with the second month in a row of record sales, this time at $350K and pacing the Commercial & Industrial Division at $4.2 million annual run rate. University Hospitals, a top 10 hospital in the USA, joined a Fortune 500 client in providing glowing testimonials.  Winslow Asset Management reported it purchased Innovest stock along with purchasing Amgen, and Berkshire Hathaway. “I would recommend Chagrin Safety Supply to anyone who is serious about implementing an effective, no hassle, first aid supply program,” said Robert Liott, University Hospitals Health System Manager, Occupational Safety & Risk Control Services.
  • GlobeNewswire2 months ago

    Innovest Global's Call Center Contract Billings With Fortune 500 Company to Exceed $1 Million Over First Twelve Months -- Spotlight Growth

    A new update has been published on Innovest Global, Inc. (OTC PINK: IVST). Innovest Global, Inc. is a diversified holding company that focuses on acquiring niche, high-growth businesses that are capable of generating significant annual revenue. In addition, growing awareness of global climate change has had an impact on the energy efficiency market.

  • News
    GlobeNewswire2 months ago

    Innovest Global, Inc. Call Center Wins $650,000 Exclusive Contract with Fortune 500 Company

    Innovest Global, Inc. (OTC PINK:IVST) Call Center has won a $650,000 contract as the exclusive provider, for an industry leading medical supply division of a Fortune 500 company, with over $2 billion in annual revenue. After a congratulatory phone call from the client CEO, the Senior Vice President followed up via email, and stated, “It gives me great pleasure to follow up with you … and notify you officially, that you have been selected as the sole partner… for our Customer Service Call Center Outsource Project.” He went on to cite the “outstanding relationship and quality of work” as reasons for their enthusiasm and selection of Innovest, in the months-long, highly competitive process. This is the single largest contract for Innovest, since launching of the Commercial & Industrial Division six months ago.

  • News
    GlobeNewswire2 months ago

    Innovest Global: Winslow Asset Management Initiates New Position During First Quarter 2018 -- Spotlight Growth

    Spotlight Growth has published new content on Innovest Global, Inc. (OTC PINK: IVST). Innovest Global, Inc. is a diversified holding company that focuses on acquiring niche, high-growth businesses that are capable of generating significant annual revenue. In addition, growing awareness of global climate change has had an impact on the energy efficiency market.

  • News
    GlobeNewswire2 months ago

    Details of Innovest Global Inc. Rapidly Growing $4 Million Revenue Commercial & Industrial Division Released, and Plans to Continue Triple Digit Growth

    Innovest Global Inc. (OTC PINK:IVST) has released the details behind its Commercial & Industrial division, which in a few short months has gone from zero to over $4 million in annual revenue run rate. The Innovest Commercial & Industrial Division is an exceptional growth story in the Commercial & Industrial space. The division has multiple organic growth hotspots, and acquisition candidates in the pipeline, both of which are strategies management anticipates will continue to fuel Division sales growth.
  • News
    GlobeNewswire2 months ago

    Innovest Global, Inc. Energy Group Signs High Five-Figure Sales Contract to Upgrade a 200,000 Sq. Ft. Facility, Another LEEP Project

    Innovest Global, Inc. (OTC PINK:IVST) Energy Group has signed another significant client thanks to its revolutionary LEEP financing program. Using the LEEP Program, they became the latest Energy Group client to upgrade without dipping into their cash, or adding to their monthly expenses. The LEEP Program makes the green upgrade decision easy.

  • News
    GlobeNewswire3 months ago

    Innovest Global Ripe For Short Squeeze After Announcing Record Monthly Sales of $326K, Major Sales Contracts, and Acquisitions -- Spotlight Growth

    Spotlight Growth has published new content on Innovest Global, Inc. (OTC PINK: IVST). Innovest Global, Inc. is a diversified holding company that focuses on acquiring niche, high-growth businesses that are capable of generating significant annual revenue. The report provides an overview of Innovest Global, Inc., its subsidiaries, financials, industry analysis and more.

  • News
    GlobeNewswire3 months ago

    May Shareholder Update, Innovest Global, Inc. Had Record $326K Sales in April and Several Significant Accomplishments

    Innovest Global Inc. (OTC PINK:IVST) finished April with the highest monthly sales the company has recorded to date, $326K from its Commercial & Industrial Division. This includes information that may be material, so please follow us and visit our website regularly! For more information on Innovest contact info@innovestglobal.com, or call Innovest investor Relations Matt Rego at 216.815.1122.

  • News
    GlobeNewswire3 months ago

    Innovest Global, Inc. Call Center Wins 5 Figure Contract With National Software Leader

    Innovest Global, Inc. (OTC PINK:IVST) Call Center has won a significant bid for a contract with industry leader MRI Software, which has high compliance requirements - an Innovest Call Center expertise, since acquiring Crestwood Management in January. MRI Software serves Public Housing Authorities (PHAs) in 44 states through its subsidiary Tenmast, including Guam and Saipan in the South Pacific and is focused on helping them manage compliance with HUD regulations.

  • News
    GlobeNewswire3 months ago

    Innovest Global Signs Two Energy Contracts Totaling 6 Figures, Announces Update On Audit and Uplisting Plans -- Spotlight Growth

    A new update has been published on Innovest Global, Inc. (OTC PINK: IVST). Innovest Global, Inc. is a diversified holding company that focuses on acquiring niche, high-growth businesses that are capable of generating significant annual revenue. The report provides an overview of Innovest Global, Inc., its subsidiaries, financials, industry analysis and more.

  • News
    GlobeNewswire3 months ago

    Innovest Global, Inc. Signed LOI to Acquire Forensic Energy Auditing Firm with $500K Annual Revenue

    Innovest Global, Inc. (OTC PINK:IVST) Commercial & Industrial Division has signed a Letter of Intent to acquire an Energy business specializing in forensic energy auditing, and energy reduction strategy recommendations for high energy use clients. Innovest has signed of a Letter of Intent to acquire 100% ownership of the company, which is a perfect foundation for the “consultancy” pillar of the one-stop business model. The Energy Group business model is consultancy, procurement, and efficiency solutions for high energy use clients.

  • News
    GlobeNewswire3 months ago